These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35234810)

  • 21. Real-World Data for Pulmonary Arterial Hypertension.
    Elliott CG
    Chest; 2019 Apr; 155(4):653-654. PubMed ID: 30955564
    [No Abstract]   [Full Text] [Related]  

  • 22. A Novel Peptide for Immunomodulation in Pulmonary Arterial Hypertension.
    Grinnan D; Farkas L
    Am J Respir Crit Care Med; 2019 Jun; 199(12):1460-1461. PubMed ID: 30973752
    [No Abstract]   [Full Text] [Related]  

  • 23. [Research progress on the role of gas signal molecules on pulmonary arterial hypertension].
    Wang MJ; Tang YY; Yu ZX
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Jan; 50(1):14-19. PubMed ID: 35045609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hit Early and Hit Hard in Pulmonary Arterial Hypertension? Not So Fast!
    Hassoun PM; Farber HW
    Am J Respir Crit Care Med; 2021 Oct; 204(7):755-756. PubMed ID: 34402772
    [No Abstract]   [Full Text] [Related]  

  • 25. Request to "Update" the 2019 Update of Guidelines for Management of Pulmonary Arterial Hypertension.
    Durrani J; Toor A
    Chest; 2019 Jul; 156(1):187. PubMed ID: 31279369
    [No Abstract]   [Full Text] [Related]  

  • 26. [Diagnosis of idiopathic pulmonary arterial hypertension by "3P" algorithm].
    Fan FL; Zhang SL; Song Q; Xie XG; Zhang YP; Huo XW; Zou YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):621-625. PubMed ID: 32842275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EpiHope for the Treatment of Pulmonary Arterial Hypertension: Selective versus Nonselective BET Inhibition.
    Pullamsetti SS; de Jesus Perez VA
    Am J Respir Crit Care Med; 2019 Nov; 200(9):1188-1190. PubMed ID: 31419389
    [No Abstract]   [Full Text] [Related]  

  • 28. The Janus Faces of Bone Morphogenetic Protein 9 in Pulmonary Arterial Hypertension.
    Ormiston ML; Godoy RS; Chaudhary KR; Stewart DJ
    Circ Res; 2019 Mar; 124(6):822-824. PubMed ID: 30870124
    [No Abstract]   [Full Text] [Related]  

  • 29. Still puzzling about a clear definition of pulmonary arterial hypertension in newborns.
    Calcaterra G; Fanos V; Bassareo PP
    Eur Respir J; 2019 Mar; 53(3):. PubMed ID: 30923176
    [No Abstract]   [Full Text] [Related]  

  • 30. Pulmonary Hypertension Associated With Respiratory Diseases　- Which Patients Should Be Treated With Pulmonary Arterial Hypertension-Targeted Therapies?
    Sakamaki F; Asano K
    Circ J; 2021 Mar; 85(4):343-344. PubMed ID: 33563867
    [No Abstract]   [Full Text] [Related]  

  • 31. Protease-activated receptor 1 as potential therapeutic target in pulmonary arterial hypertension.
    Merkus D; van Beusekom HMM; Boomars KA
    Cardiovasc Res; 2019 Jul; 115(8):1260-1261. PubMed ID: 30903137
    [No Abstract]   [Full Text] [Related]  

  • 32. Pulmonary arterial hypertension and COVID-19: Piecing the puzzle.
    Charif F; Dakroub F; Bou Akl I; Kularatne M; Montani D
    Respir Med Res; 2023 Nov; 84():101053. PubMed ID: 38236767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response: Still puzzling about a clear definition of pulmonary arterial hypertension in newborns.
    Rosenzweig EB; Abman SH; Berger RMF
    Eur Respir J; 2019 Mar; 53(3):. PubMed ID: 30923178
    [No Abstract]   [Full Text] [Related]  

  • 34. Endothelial CFTR dysfunction and its involvement in the pathogenesis of pulmonary arterial hypertension.
    Declercq M; Treps L; Bousfia S; Carmeliet P; Witters P
    Eur Respir J; 2021 Aug; 58(2):. PubMed ID: 34385264
    [No Abstract]   [Full Text] [Related]  

  • 35. The role of genetics in pulmonary arterial hypertension associated with congenital heart disease.
    Cruz-Utrilla A; Gallego N; Segura de la Cal T; Tenorio-Castaño J; Arribas-Ynsaurriaga F; Escribano Subias P
    Rev Esp Cardiol (Engl Ed); 2021 Oct; 74(10):884-886. PubMed ID: 33972189
    [No Abstract]   [Full Text] [Related]  

  • 36. Palliative care referrals in patients with pulmonary arterial hypertension: The Pulmonary Hypertension Association Registry.
    Rohlfing AB; Bischoff KE; Kolaitis NA; Kronmal RA; Kime NA; Gray MP; Bartolome S; Chakinala MM; Frantz RP; Ventetuolo CE; Mathai SC; De Marco T;
    Respir Med; 2023 Jan; 206():107066. PubMed ID: 36470050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COUNTERPOINT: Should Initial Combination Therapy Be the Standard of Care in Pulmonary Arterial Hypertension? No.
    Channick RN; Saggar R
    Chest; 2019 Dec; 156(6):1043-1045. PubMed ID: 31812189
    [No Abstract]   [Full Text] [Related]  

  • 38. Performance of the ESC/ERS 4-strata risk stratification model for pulmonary arterial hypertension with missing variables.
    Pausch C; Pittrow D; Hoeper MM; Huscher D
    Eur Respir J; 2023 Nov; 62(5):. PubMed ID: 37802633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determining the Architecture of Inflammation in Pulmonary Arterial Hypertension.
    Rajagopal S; Yu YR
    Am J Respir Crit Care Med; 2024 Jan; 209(2):131-133. PubMed ID: 38033319
    [No Abstract]   [Full Text] [Related]  

  • 40. Surrogate endpoints in pulmonary arterial hypertension trials.
    Hoeper MM
    Lancet Respir Med; 2023 Oct; 11(10):852-853. PubMed ID: 37230096
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.